Ascentage Pharma Group International (AAPG) Accounts Payables (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Accounts Payables for 3 consecutive years, with $15.0 million as the latest value for Q4 2025.
- For Q4 2025, Accounts Payables rose 17.55% year-over-year to $15.0 million; the TTM value through Dec 2025 reached $15.0 million, up 17.55%, while the annual FY2025 figure was $15.3 million, 21.15% up from the prior year.
- Accounts Payables hit $15.0 million in Q4 2025 for Ascentage Pharma Group International, up from $12.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $15.0 million in Q4 2025 and bottomed at $10.1 million in Q4 2023.
- Average Accounts Payables over 3 years is $12.6 million, with a median of $12.8 million recorded in 2024.
- Year-over-year, Accounts Payables rose 27.25% in 2024 and then rose 17.55% in 2025.
- Ascentage Pharma Group International's Accounts Payables stood at $10.1 million in 2023, then grew by 27.25% to $12.8 million in 2024, then rose by 17.55% to $15.0 million in 2025.
- According to Business Quant data, Accounts Payables over the past three periods came in at $15.0 million, $12.8 million, and $10.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.